NLRP3 inflammasome in cardiovascular diseases: molecular mechanisms and advances in targeted drug research.
- DOI
- 10.3389/fimmu.2026.1848762
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1848762,
title = {NLRP3 inflammasome in cardiovascular diseases: molecular mechanisms and advances in targeted drug research.},
author = {Zhang T and Luo L and Yang K and Liu H and Xiao S and Wang M and Chen J and Zhou Y and Ge L},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1848762},
url = {https://doi.org/10.3389/fimmu.2026.1848762}
}RIS
TY - JOUR TI - NLRP3 inflammasome in cardiovascular diseases: molecular mechanisms and advances in targeted drug research. AU - Zhang T AU - Luo L AU - Yang K AU - Liu H AU - Xiao S AU - Wang M AU - Chen J AU - Zhou Y AU - Ge L PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1848762 UR - https://doi.org/10.3389/fimmu.2026.1848762 ER -
APA
T, Z., L, L., K, Y., H, L., S, X., M, W., J, C., Y, Z., & L, G. (2026). NLRP3 inflammasome in cardiovascular diseases: molecular mechanisms and advances in targeted drug research.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1848762
Source records
- pubmed · retrieved 2026-09-25T12:48:02.120Z